An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

In this section: Vaccines, Blood & Biologics

MenQuadfi

BL: 125701
Proper Name: Meningococcal (Groups A, C, Y, W) Conjugate Vaccine
Tradename: MenQuadfi
Manufacturer: Sanofi Pasteur, Inc.
Indication:

MenQuadfi is a vaccine indicated for active immunization for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W, and Y. MenQuadfi is approved for use in individuals 2 years of age and older.
MenQuadfi does not prevent N. meningitidis serogroup B disease.

Product Information

Package Insert - MenQuadfi
Demographic Subgroup Information – Meningococcal (Groups A, C, Y, W) Conjugate Vaccine (MenQuadfi)
Refer to Section 1.1 of the Clinical Review Memo for information about participation in the clinical trials and any analysis of demographic subgroup outcomes that is notable.

Supporting Documents

Top